Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
Conditions
- Atrial Fibrillation (AF)
- Chronic Lymphocytic Leukemia
- Waldenstrom Macroglobulinemia
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
Sponsor
Tina Baykaner